Live from our Cancer Research Institute seminar: Vinod Balachandran, MD @mskcancercenter.bsky.social. Using reverse translation to uncover a biological basis of exceptional response in #PancreaticCancer survivors, his lab identifies mechanisms in model systems and accelerate new immunotherapies.

uPAR CAR T cells eradicate primary and metastatic solid tumors with minimal myelodepletion by targeting both tumor cells and the stroma in preclinical models @cellcellpress.bsky.social @lowelab.bsky.social @mskcancercenter.bsky.social @columbiauniversity.bsky.social www.cell.com/cell/fulltex...

In a @nejm.org editorial, our leader Deb Schrag reflected on 30 years of incredible progress in #coloncancer treatment and identified opportunities to harness insights from biomarker testing to customize therapies that reduce side effects. @mskcancercenter.bsky.social#coloncancer 📖 https://bit.ly/4clZWoH

MSK researchers and their collaborators have developed a new type of CAR T cell designed to target a cell surface protein called uPAR, which is found on cancer cells as well as supportive cells in the tumor microenvironment. (1/3)

Subscribe to our quarterly newsletter, MSK Discoveries, to stay up to date with the latest research news — from clinical innovations to foundational biological insights: https://bit.ly/4bVSjop

MSK gastrointestinal medical oncologist Dr. Wungki Park led a global phase 1 clinical trial of #setidegrasib, which shows early promise in aggressive #lung and #pancreatic cancers. Learn more about this research: https://bit.ly/3Nsijjm

“Think of a chatbot as a research assistant rather than a decision-maker,” says MSK's Dr. James Janopaul-Naylor. MSK experts share how to use #AI chatbots to get reliable information and emphasize the importance of confirming what patients learn with their care team: https://bit.ly/4sNLFre

MSK would like to welcome Steve Glass, our new Executive Vice President and Chief Financial Officer. At MSK, Steve will work closely with leadership across the institution to support the organization’s continued growth and mission to end cancer for life. Learn more: https://bit.ly/4bwOc22

Lonny Yarmus named head of the Division of Subspecialty Medicine at MSK (@mskcancercenter.bsky.social) https://cancerletter.com/in-brief/20260313_7c/

Congratulations to MSK's Dr. @AndreaCercek and Dr. Luis Diaz for being accepted into Round 3 of @statnews.com #STATMadness. Vote for their team now: https://bit.ly/3FfcuRu

Just out in @natgenet.nature.com: Research led by Dr. Omar Abdel-Wahab of MSK & Dr. Kelly Bolton of WashU Medicine offers a new method to prevent the development of chemotherapy-induced leukemia — one of the most lethal complications of cancer therapy for solid tumors. www.nature.com/articles/s41...

MSK would like to welcome physician-scientist Dr. Lonny Yarmus, our new Head of the Division of Subspecialty Medicine in the Department of Medicine at MSK. Learn more about Dr. Yarmus: https://bit.ly/46RZv3q

Congratulations to MSK's Dr. Viviane Tabar and Dr. Lorenz Studer for being accepted into Round 2 of @statnews.com #STATMadness. Vote for their team now: https://bit.ly/3FfcuRu

Congratulations to MSK's Dr. Andrea Cercek and Dr. Luis Diaz for being accepted into Round 2 of @statnews.com #STATMadness. Vote for their team now: https://bit.ly/3FfcuRu

New from @nature.com: A team led by MSK breast medical oncologist Dr. Pedram Razavi found that tumors with germline #BRCA2 mutations or homologous recombination deficiency (HRD) are more likely to develop RB1 loss during treatment with CDK4/6 inhibitors, leading to therapeutic resistance.

Very excited to have been awarded a Cancer Grand Challenge grant as part of team REWIRE-CAN @cancergrand.bsky.social to develop new approaches to combat cancer #plasticity. Our goal: to see all #colorectalcancer patients become colorectal cancer survivors.

🎉 Congratulations to MSK physician-scientist @karunamdphd.bsky.social and colleagues, who are part of an international team awarded a Cancer Grand Challenges grant — a prestigious global award providing up to $25M over five years to tackle some of the toughest challenges in #cancerresearch.

Congratulations to MSK's Dr. Andrea Cercek and Dr. Luis Diaz for being accepted into Round 1 of @statnews.com's #STATMadness. Vote for their team now: https://bit.ly/3FfcuRu

Congratulations to MSK's Dr. Viviane Tabar and Dr. Lorenz Studer for being accepted into Round 1 of @statnews.com's #STATMadness. Vote for their team now: https://bit.ly/3FfcuRu

New research from MSK investigates harnessing the power of #ferroptosis to spread cell death; reports how an MSK artificial intelligence (AI) model could help improve patient safety; and uses #AI to reveal country-specific drivers of global cancer outcomes. Learn more: https://bit.ly/47hDB9N

At @ascocancer.bsky.social #GU26, Robert Motzer presented phase 3 trial results that showed belzutifan + lenvatinib achieved superior PFS & ORR compared with cabozantinib in people with advanced #kidneycancer who progressed after immunotherapy. @mskcancercenter.bsky.social#GU26#kidneycancer🔗 https://bit.ly/4r4AYPD

Sensitive CAR T cells redefine targetable CD70 expression in solid tumors @science.org #Sadelain @mskcancercenter.bsky.social @columbiauniversity.bsky.social www.science.org/doi/10.1126/...

Congrats to MSK's most recent Awards and Appointments, including Dr. Selwyn Vickers for being named among @oncodaily.bsky.social's “100 Most Influential CEOs in Oncology 2025," and more: bit.ly/4qZvYvE.

Many thanks to Harold K. Elias, MD, Senior Research Scientist at @mskcancercenter.bsky.social, for presenting the Feb. 18 Laboratory Medicine Grand Rounds. Here’s Dr. Elias, right, with his host Diane Krause, MD, PhD, Anthony N. Brady Professor of Laboratory Medicine @yaleschoolofmed.bsky.social

Friday 2/20 at 4pm: Friday Cancer Center Seminar Series @ucsanfrancisco.bsky.social | Andrea Ventura, MD, PhD, Cancer biologist @mskcancercenter.bsky.social presents "Engineering the Cancer Genome: from gene fusions to ecDNAs" Info: cancer.ucsf.edu/seminars

Years of CAR T research led to a breakthrough for AL amyloidosis and a clinical trial led by Dr. Heather Landau. Dr. Karlo Perica is advancing its potential for other cancers. Our Saved by Science series captures the emotional meetings b/w patients & the scientists transforming care. Watch more ⬇️

A clinical trial led by MSK’s Dr. Heather Landau using CAR T cell therapy helped Maureen and other patients with relapsed light chain (AL) amyloidosis. In just a week, her biomarkers returned to normal. Learn from MSK's Dr. Karlo Perica how CAR T therapy is shaping the future of patient care.

After 20 years of fighting a rare blood disease, Maureen joined an MSK trial, led by Dr. Heather Landau. Dr. Karlo Perica explains how #CART therapy re-engineered her immune cells to attack the disease. Just one week after her CAR T cell infusion, Maureen’s blood tests were normal.

Every medical breakthrough begins with a decades-long journey in the lab. Our Saved by Science series, captures the emotional meetings between patients and the scientists, including MSK's Dr. David Solit, whose years of research have given them new hope. Watch on YouTube: https://bit.ly/4bRHtSe

🧬 Dr. Jungeui Hong and team at @mskcancercenter.bsky.social provide a high-level profile of the genetic features distinguishing locally advanced from metastatic PDAC, serving as a biomarker of PDACs most likely to benefit from neoadjuvant chemoradiation. https://bit.ly/4aFGZgP

After participating in an MSK clinical trial, led by gynecological oncologist Dr. Rachel Grisham & based on research by physician-scientist Dr. David Solit, Ellen, an MSK #ovariancancer patient, got early access to a treatment that has dramatically shrunk her tumors and changed her outlook on life.

Honored to be among this year's cohort of grant awardees from the @nihcm.bsky.social ! Drs. Aaron Winn, Pragya Kakani, and I will be studying trends in provider profit margins on cancer drugs. @mskcancercenter.bsky.social @ascocancer.bsky.social nihcm.org/news/nihcm-a...

Ellen was diagnosed with a rare and hard to treat #ovariancancer. Everything changed when she enrolled in a clinical trial led by Dr. Rachel Grisham, based on a lab discovery years ago by Dr. David Solit. Watch more Saved by Science stories on YouTube: https://bit.ly/3ZLODjv

🎉 Congrats to Luis Diaz Jr., MD, on receiving the 2026 Gustave Roussy Award - Honored for groundbreaking work in precision oncology. 👉https://lfdn.org/3NXPdIs #ResearchIsFundamental @mskcancercenter.bsky.social @gustaveroussy.fr

Congratulations to MSK's Dr. Luis Diaz on receiving the Gustave Roussy Prize, presented to a prominent figure whose scientific breakthroughs in cancer diagnosis, treatment, or prevention have significantly improved patient care and advanced our understanding of the disease. 👏

At #Tandem26, don't miss Dr. Mohammad Alhomoud's presentation, "Cartiac: Comparative Cardiovascular Safety of CAR T Products for Non-Hodgkin’s Lymphoma – a Propensity Score–Matched International Multicenter Study." 📍 Feb 4, 4:15 PM MST ➡️ https://bit.ly/49XCUEv @mskcancercenter.bsky.social#Tandem26

At #Tandem26, @drmiguelperales.bsky.social, MSK's Adult Bone Marrow Transplant Chief and past @astct.bsky.social President, will present research on new tools to help predict one-year survival for transplant recipients. @mskcancercenter.bsky.social 📍Feb 4, 11:15 a.m. MST ➡️ bit.ly/4tg4Rz1

Dr. Sergio Giralt is kicking off #Tandem26 for @mskcancercenter.bsky.social! Join his session to learn about the latest CAR T cell therapies for #multiplemyeloma. 📍 Feb 4, 9:05 a.m.–9:35 a.m. MST | Room 255 A-G ➡️ https://bit.ly/4rgYf25 @astct.bsky.social @cibmtr.bsky.social#Tandem26#multiplemyeloma#mmsm

Make sure to attend this great session at #tandem26 looking fwd to great talk by @mskcancercenter.bsky.social Dr Susan Dewolf and other great speakers @mskdeptofmed.bsky.social

(1/2) Neuro-oncologist Dr. Adrienne Boire teamed up with computational biologist Dr. Dana Pe’er to find a way to stop cancer cells from surviving in the cerebrospinal fluid.

MSK, in partnership with Obafemi Awolowo University, Lagos University Teaching Hospital, and Medserve, has launched a ground-breaking clinical trial aimed at transforming treatment options and standard of care for patients with #colorectalcancer in Nigeria. https://bit.ly/4qY2Iq7

New study @nature.com defining the ontogeny of Thetis cells and the developmental cues that shape their early-life wave of differentiation @mskcancercenter.bsky.social @chrysothemisbrown.bsky.social nature.com/articles/s41...

A treatment discovered through a collaboration between MSK computational biologist Dr. Dana Pe’er and MSK neuro-oncologist Dr. Adrienne Boire, has given Carlos, an MSK stage 4 #lungcancer patient, more time with his family and a much better quality of life. Watch more: https://bit.ly/4tdAmth

Just out in @nature.com: Findings from MSK researchers will facilitate future investigations of Thetis cells and efforts to harness their therapeutic potential against food allergies and autoimmune diseases. https://go.nature.com/46lMnmL

Don’t miss your opportunity to join our live CME courses this February and March. Explore full program details and register today: bit.ly/MSKCME @mskcancercenter.bsky.social

Researchers at MSK are studying the intricacies of metastatic disease to develop new ways to treat it and improve outcomes for patients with stage 4 #cancer. Learn how MSK is making progress against #metastasis.

New research from MSK sheds new light on how the gut protects itself by sensing gut bacteria; finds a subtype of #glioma-associated macrophages that appear to play a pivotal role in progression; and more.

New research at MSK shows how dormant #metastatic cancer cells prevent the immune system from eliminating them by changing their shape. The findings illuminate how cancer cells physically adapt to survive. Learn more ⬇️

#NatMetabPicks | In @cp-devcell.bsky.social led by L Studer ( @mskcancercenter.bsky.social ) Cholesterol imbalance is a common driver of neuronal dysfunction in several hPSC-derived models of major depressive disorder. 🧪 www.cell.com/developmenta...